Open AccessMultidrug-resistant tuberculosis in Rawalpindi, Pakistan
Author(s) -
Muhammad Khurram,
Hamama tul Bushra Khaar,
Muhammad Faisal Fahim
Publication year - 2011
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.1738
Subject(s) - medicine , ethambutol , pyrazinamide , tuberculosis , rifampicin , streptomycin , isoniazid , drug resistance , ofloxacin , ciprofloxacin , surgery , antibiotics , pathology , microbiology and biotechnology , biology
Multidrug-resistant (MDR) tuberculosis (TB) strains are resistant to isoniazid and rifampicin. Clinical characteristics, drug susceptibility patterns, and outcomes of MDR-TB patients treated at Holy Family Hospital, Rawalpindi, Pakistan, were studied from January 2007 to April 2010.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom